Myelopolyneuropathy and pancytopenia due to copper deficiency and high zinc levels of unknown origin II. The denture cream is a primary source of excessive zinc

NeuroToxicology

Volumn 30, Issue 6, 2009, Pages 996-999

  Hedera, Peter ^a   Peltier, Amanda ^a   Fink, John K ^b,c   Wilcock, Sandy ^b   London, Zachary ^b   Brewer, George J ^b  

^a VANDERBILT UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

Copper; Denture cream; Myelopathy; Zinc

Indexed keywords

COPPER; ZINC;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADULT; AGED; ARTICLE; BONE MARROW SUPPRESSION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; COPPER BLOOD LEVEL; COPPER DEFICIENCY; DENTURE; DIET SUPPLEMENTATION; EXPOSURE; FEMALE; HUMAN; HYPERZINCEMIA; MALE; NEUROLOGIC EXAMINATION; PANCYTOPENIA; POLYNEUROPATHY; PRIORITY JOURNAL; ZINC BLOOD LEVEL; ZINC URINE LEVEL;

ADULT; AGED; COPPER; DENTURES; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCYTOPENIA; PERIPHERAL NERVOUS SYSTEM DISEASES; SPINAL CORD DISEASES; ZINC;

EID: 71049171649     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuro.2009.08.008     Document Type: Article

References (26)

1. Brewer G.J. Neurologically presenting Wilson's disease: epidemiology, pathophysiology and treatment. CNS Drugs 19 (2005) 85-192
2. Brewer G.J., Schoomaker E.B., Leichtman D.A., Kruckleberg W.C., Brewer L.F., and Myers N. The uses of pharmacologic doses of zinc in the treatment of sickle cell anemia. In: Brewer G.J., and Prasad A.S. (Eds). Zinc metabolism: current aspects in health and disease (1977), Allan R Liss Inc., New York, NY 241-258
3. Brewer G.J., Hill G.M., Dick R.D., et al. Treatment of Wilson's disease with zinc: III. Prevention of reaccumulation of hepatic copper. J Lab Clin Med 109 (1987) 526-531
4. Brewer G.J., Yuzbasiyan-Gurkan V., Lee D.Y., and Appelman H. Treatment of Wilson's disease with zinc. VI. Initial treatment studies. J Lab Clin Med 114 (1989) 633-638
5. Brewer G.J., Yuzbasiyan-Gurkan V., Johnson V., Dick R.D., and Wang Y. Treatment of Wilson's disease with zinc XII: dose regimen requirements. Am J Med Sci 305 (1993) 199-202
6. Brewer G.J., Dick R.D., Johnson V.D., Brunberg J.A., Kluin K.J., and Fink J.K. Treatment of Wilson's disease with zinc: XV long-term follow-up studies. J Lab Clin Med 132 (1998) 264-278
7. Brewer G.J., Fink J.K., and Hedera P. Diagnosis and treatment of Wilson disease. Semin Neurol 19 (1999) 261-270
8. Broun E.R., Greist A., Tricot G., and Hoffman R. Excessive zinc ingestion: a reversible cause of sideroblastic anemia and bone marrow depression. JAMA 264 (1990) 1441-1443
9. Greenberg S.A., and Briemberg H.R. A neurological and hematological syndrome associated with zinc excess and copper deficiency. J Neurol 251 (2004) 111-114
10. Gyorffy E.J., and Chan H. Copper deficiency and microcytic anemia resulting from prolonged ingestion of over-the-counter zinc. Am J Gastroenterol 87 (1992) 1054-1055
11. Hedera P., and Brewer G.J. Letter to the Editor. Reply. Myelopolyneuropathy and pancytopenia due to copper deficiency and high zinc levels of unknown source: further support for existence of a new zinc overload syndrome. Arch Neurol 61 (2004) 605
12. Hedera P., Fink J.K., Bockenstadt P.L., and Brewer G.J. Myelopolyneuropathy and pancytopenia due to copper deficiency and high zinc levels of unknown source: further support for existence of a new zinc overload syndrome. Arch Neurol 60 (2003) 1303-1306
13. Hoffman H.N., Phyliky R.L., and Fleming C.R. Zinc-induced copper deficiency. Gastroenterology 94 (1988) 508-512
14. Kumar N. Copper deficiency myelopathy (human swayback). Mayo Clin Proc 81 (2006) 1371-1384
15. Kumar N., McEvoy K.M., and Ahlskog J.E. Myelopathy due to copper deficiency following gastrointestinal surgery. Arch Neurol 60 (2003) 1782-1785
16. Kumar N., Gross Jr. J.B., and Ahlskog J.E. Myelopathy due to copper deficiency. Neurology 61 (2003) 273-274
17. Kumar N., Gross J.B., and Ahlskog J.E. Copper deficiency myelopathy produces a clinical picture like subacute combined degeneration. Neurology 63 (2004) 33-39
18. Kumar N., Crum B., Petersen R.C., Vernino S.A., and Ahlskog J.E. Copper deficiency myelopathy. Arch Neurol 61 (2004) 762-766
19. Nations S.P., Boyer P.J., Love L.A., et al. Denture cream: an unusual source of excess zinc, leading to hypocupremia and neurologic disease. Neurology 71 (2008) 634-639
20. Prasad A.S., Brewer G.J., Schoomaker E.B., and Rabbini P. Hypocupremia induced by zinc therapy in adults. JAMA 240 (1978) 2166-2168
21. Prodan C.I., Holland N.R., Wisdom P.J., Burstein S.A., and Bottomley S.S. CNS demyelinization associated with copper deficiency and hyperzincemia. Neurology 59 (2002) 1453-1456
22. Schleper B., and Stuerenburg H.J. Copper deficiency-associated myelopathy in a 46-year-old woman. J Neurol 248 (2001) 705-706
23. Spinazzi M., and Armani M. Letter to the Editor. Reply. Denture cream: an unusual source of excess zinc, leading to hypocupremia and neurologic disease. Neurology 73 (2009) 76
24. Spinazzi M., De Lazzari F., Tavolato B., Angelini C., Manara R., and Armani M. Myelo-optico-neuropathy in copper deficiency occurring after partial gastrectomy. Do small bowel bacterial overgrowth syndrome and occult zinc ingestion tip the balance?. J Neurol 254 (2007) 1012-1027
25. Tan J.C., Burns D.L., and Jones H.R. Severe ataxia, myelopathy, and peripheral neuropathy due to acquired copper deficiency in a patient with a history of gastrectomy. JPEN Parenter Enteral Nutr 30 (2006) 446-450
26. Yuzbasiyan-Gurkan V., Grider A., Nostrant T., Cousins R.J., and Brewer G.J. Treatment of Wilson's disease with zinc: X. Intestinal metallothionein induction. J Lab Clin Med 120 (1992) 380-386